[go: up one dir, main page]

AR018829A1 - Formulaciones farmaceuticas solidas de rapida desintegracion, administrables via oral y procedimiento para prepararlos - Google Patents

Formulaciones farmaceuticas solidas de rapida desintegracion, administrables via oral y procedimiento para prepararlos

Info

Publication number
AR018829A1
AR018829A1 ARP990101500A ARP990101500A AR018829A1 AR 018829 A1 AR018829 A1 AR 018829A1 AR P990101500 A ARP990101500 A AR P990101500A AR P990101500 A ARP990101500 A AR P990101500A AR 018829 A1 AR018829 A1 AR 018829A1
Authority
AR
Argentina
Prior art keywords
prepare
procedure
solid pharmaceutical
pharmaceutical formulations
via oral
Prior art date
Application number
ARP990101500A
Other languages
English (en)
Original Assignee
Viatris Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Viatris Gmbh filed Critical Viatris Gmbh
Publication of AR018829A1 publication Critical patent/AR018829A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • A61K31/515—Barbituric acids; Derivatives thereof, e.g. sodium pentobarbital
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Molecular Biology (AREA)
  • Emergency Medicine (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Formulaciones farmacéuticas solidas de administracion vía oral y de rápida desintegracion, de sustancias activas susceptibles a los álcalis,especialmente la selegilina, en forma de formulaciones efervescentes que contienen una sustancia activa susceptible a los álcalis y una base efervescente queconsiste en uno o varios carbonatos de metales alcalino-térreos, un ácido orgánico comestible y/o una sal de metal alcalino y ácido cítrico y, dado elcaso, sustancias auxiliares farmacéuticamente utilizables. También se propone un procedimiento para preparar dichas formulaciones.
ARP990101500A 1998-03-31 1999-03-31 Formulaciones farmaceuticas solidas de rapida desintegracion, administrables via oral y procedimiento para prepararlos AR018829A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19814257A DE19814257A1 (de) 1998-03-31 1998-03-31 Brauseformulierungen

Publications (1)

Publication Number Publication Date
AR018829A1 true AR018829A1 (es) 2001-12-12

Family

ID=7863015

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP990101500A AR018829A1 (es) 1998-03-31 1999-03-31 Formulaciones farmaceuticas solidas de rapida desintegracion, administrables via oral y procedimiento para prepararlos

Country Status (28)

Country Link
US (1) US6242002B1 (es)
EP (1) EP1067905B1 (es)
JP (1) JP4469494B2 (es)
KR (1) KR100607395B1 (es)
CN (1) CN1138529C (es)
AR (1) AR018829A1 (es)
AT (1) ATE224703T1 (es)
AU (1) AU753194B2 (es)
BG (1) BG65043B1 (es)
BR (1) BR9909266A (es)
CA (1) CA2326502C (es)
CZ (1) CZ300705B6 (es)
DE (2) DE19814257A1 (es)
DK (1) DK1067905T3 (es)
ES (1) ES2183555T3 (es)
HU (1) HU229793B1 (es)
IL (1) IL138605A (es)
NO (1) NO329143B1 (es)
NZ (1) NZ506989A (es)
PL (1) PL192049B1 (es)
PT (1) PT1067905E (es)
RU (1) RU2221554C2 (es)
SK (1) SK284477B6 (es)
TR (1) TR200002812T2 (es)
TW (1) TW580398B (es)
UA (1) UA66847C2 (es)
WO (1) WO1999049842A1 (es)
ZA (1) ZA200005133B (es)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6974590B2 (en) 1998-03-27 2005-12-13 Cima Labs Inc. Sublingual buccal effervescent
US20030118645A1 (en) * 1998-04-29 2003-06-26 Pather S. Indiran Pharmaceutical compositions for rectal and vaginal administration
US6200604B1 (en) * 1998-03-27 2001-03-13 Cima Labs Inc. Sublingual buccal effervescent
US20030091629A1 (en) * 1998-03-27 2003-05-15 Cima Labs Inc. Sublingual buccal effervescent
US6350470B1 (en) 1998-04-29 2002-02-26 Cima Labs Inc. Effervescent drug delivery system for oral administration
AU2007203233B2 (en) * 1999-03-26 2010-02-25 Cima Labs Inc. Sublingual buccal effervescent
AU2004242477B2 (en) * 1999-03-26 2007-04-19 Cima Labs Inc. Sublingual buccal effervescent
ATE432691T1 (de) * 2000-03-28 2009-06-15 Sandoz Ag Geschmackmaskierte granulierte teilchen
JP4706096B2 (ja) * 2000-10-23 2011-06-22 大正製薬株式会社 不快な味を呈する塩基性薬物配合製剤
US20030068356A1 (en) * 2001-07-10 2003-04-10 Pather S. Indiran Sequential drug delivery systems
GB0217056D0 (en) * 2002-07-23 2002-08-28 Ass Octel Use
US20040175456A1 (en) * 2003-03-06 2004-09-09 Lauren Keilbach Tablets for feeding fish and methods of making tablets for feeding fish
US20040191298A1 (en) * 2003-03-26 2004-09-30 Fredrik Nicklasson New formulations and use thereof
TR200300510A2 (tr) * 2003-04-18 2004-11-22 Sanovel �La� Sanay� Ve T�Caret A.�. Dağılan alendronat mikropartikül formülasyonu
US7858121B2 (en) 2003-12-31 2010-12-28 Cima Labs, Inc. Effervescent oral fentanyl dosage form and methods of administering fentanyl
WO2005065319A2 (en) 2003-12-31 2005-07-21 Cima Labs Inc. Generally linear effervescent oral fentanyl dosage form and methods of administering
CA2549642C (en) * 2003-12-31 2012-10-30 Cima Labs Inc. Effervescent oral opiate dosage forms and methods of administering opiates
US7033511B2 (en) 2004-01-20 2006-04-25 A-Dec, Inc. Sustained water treatment in dental equipment
US8216610B2 (en) * 2004-05-28 2012-07-10 Imaginot Pty Ltd. Oral paracetamol formulations
JP2008500288A (ja) * 2004-05-28 2008-01-10 イメイジノット ピーティーワイ エルティーディー 経口治療用化合物の供給系
KR100990590B1 (ko) * 2005-09-01 2010-10-29 에자이 알앤드디 매니지먼트 가부시키가이샤 붕해성이 개선된 의약 조성물의 제조 방법
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
JP2009517346A (ja) * 2005-11-28 2009-04-30 イメイジノット ピーティーワイ エルティーディー 治療用化合物の経口送達系
CN102186461A (zh) * 2008-10-14 2011-09-14 麦克内尔股份公司 多部分口腔内剂型及其用途
KR101233352B1 (ko) * 2009-04-22 2013-02-25 (주)비씨월드제약 유전자 재조합 과립구-대식세포 집락 촉진인자를 함유하는 정제
EP2440210A4 (en) 2009-06-12 2014-01-29 Meritage Pharma Inc METHOD FOR THE TREATMENT OF STOMACH DARM DISEASES
MX2013009931A (es) 2011-04-18 2013-10-01 Eisai R&D Man Co Ltd Agentes terapeuticos contra tumores.
EP2714937B1 (en) 2011-06-03 2018-11-14 Eisai R&D Management Co., Ltd. Biomarkers for predicting and assessing responsiveness of thyroid and kidney cancer subjects to lenvatinib compounds
MX2014009247A (es) 2012-02-01 2014-10-14 Intercontinental Great Brands Llc Tableta para bebida baja en calorias.
MX2015004979A (es) 2012-12-21 2015-07-17 Eisai R&D Man Co Ltd Forma amorfa de derivado de quinolina y metodo para su produccion.
NZ714049A (en) 2013-05-14 2020-05-29 Eisai R&D Man Co Ltd Biomarkers for predicting and assessing responsiveness of endometrial cancer subjects to lenvatinib compounds
CN113683564A (zh) 2014-08-28 2021-11-23 卫材R&D管理有限公司 高纯度喹啉衍生物及其生产方法
LT3263106T (lt) 2015-02-25 2024-01-10 Eisai R&D Management Co., Ltd. Chinolino darinių kartumo sumažinimo būdas
CA2978226C (en) 2015-03-04 2025-02-18 Eisai R&D Management Co., Ltd. COMBINATION OF A PD-1 ANTAGONIST AND A VEGFR/FGFR/RET TYROSINE KINASE INHIBITOR TO TREAT CANCER
CN107801379B (zh) 2015-06-16 2021-05-25 卫材R&D管理有限公司 抗癌剂
RU2718048C2 (ru) 2015-08-20 2020-03-30 Эйсай Ар Энд Ди Менеджмент Ко., Лтд. Противоопухолевое терапевтическое средство
WO2018147275A1 (ja) 2017-02-08 2018-08-16 エーザイ・アール・アンド・ディー・マネジメント株式会社 腫瘍治療用医薬組成物
RU2019134940A (ru) 2017-05-16 2021-06-16 Эйсай Ар Энд Ди Менеджмент Ко., Лтд. Лечение гепатоцеллюлярной карциномы
CN109303334B (zh) 2018-10-17 2021-04-13 汤臣倍健股份有限公司 一种口腔微泡腾片及其制备方法
PT3799864T (pt) * 2019-10-02 2023-05-25 Intas Pharmaceuticals Ltd Composições farmacêuticas sólidas efervescentes essencialmente isentas de sódio
WO2021239541A1 (en) * 2020-05-28 2021-12-02 Unilever Ip Holdings B.V. Tablet
MX2022015714A (es) 2020-06-08 2023-01-24 Nicoventures Trading Ltd Composicion oral efervescente que comprende un ingrediente activo.

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4678661A (en) * 1983-09-28 1987-07-07 Gerhard Gergely Effervescent composition and method of making same
DE3440288C2 (de) * 1984-11-05 1987-03-12 Gergely, Gerhard, Dr.-Ing., Wien Pharmazeutische Zubereitung mit einem Gehalt an Ibuprofen sowie Verfahren zu ihrer Herstellung
US4687662A (en) * 1985-08-30 1987-08-18 Warner-Lambert Company Therapeutic effervescent composition
US4861800A (en) 1987-08-18 1989-08-29 Buyske Donald A Method for administering the drug deprenyl so as to minimize the danger of side effects
US5656286A (en) 1988-03-04 1997-08-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
US5474783A (en) * 1988-03-04 1995-12-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
GB8807504D0 (en) * 1988-03-29 1988-05-05 Sandoz Ltd Improvements in/relating to organic compounds
GB8909793D0 (en) * 1989-04-28 1989-06-14 Beecham Group Plc Pharmaceutical formulation
US5128145A (en) 1990-06-13 1992-07-07 Alza Corporation Dosage form for Parkinson's disease, spasticity and muscle spasms
HU209605B (en) 1991-04-15 1994-09-28 Chinoin Gyogyszer Es Vegyeszet Process for production of wather-free transdermal preparation
ATE122228T1 (de) 1991-07-01 1995-05-15 Gergely Gerhard Verfahren zur herstellung einer pharmazeutischen zubereitung mit wenigstens zwei verschiedenen wirkstoffen und verwendung einer solchen zubereitung.
ES2053411T3 (es) * 1991-07-01 1995-05-01 Gerhard Gergely Sistemas efervescentes dotados de reaccion.
EP0593807A1 (en) 1992-10-22 1994-04-27 LTS Lohmann Therapie-Systeme GmbH & Co. KG Patch for transdermal administration of volatile pharmaceutically active ingredients of chemically basic nature and a process for preparation
MX9300110A (es) * 1992-01-13 1994-07-29 Gerhard Gergely Preparacion farmaceutica en la forma de una tableta de efervescencia o de desintegracion o de un granulado de tipo instanteneo y procedimiento para su preparacion.
WO1994000124A1 (en) 1992-06-22 1994-01-06 Eckard Weber Glycine receptor antagonists and the use thereof
DE4225730C2 (de) 1992-08-04 2003-04-30 Merz Pharma Gmbh & Co Kgaa Verfahren zur Herstellung von festen Arzneiformkörpern mit protrahierter 2-Stufen-Freisetzung
FR2698788B1 (fr) * 1992-12-09 1995-03-03 Union Pharma Scient Appl Composition pharmaceutique effervescente contenant de l'ibuprofène et son procédé de préparation.
JPH08510720A (ja) 1993-01-27 1996-11-12 アフィマックス テクノロジーズ ナームロゼ フェンノートシャップ 経皮的薬物送り出しのための組成物及び方法
US5287394A (en) 1993-03-22 1994-02-15 Advanced Micro Devices, Inc. Fast counter with uniform delay structures
SE9301112D0 (sv) 1993-04-02 1993-04-02 Orion-Yhtymae Oy A new composition
EP0624364B1 (de) * 1993-04-15 1996-07-24 Gerhard Dr. Gergely Brausesystem mit einem alkali- und/oder metallempfindlichen, pharmazeutischen Wirkstoff, und Verfahren zur Herstellung
JP3489831B2 (ja) 1993-04-20 2004-01-26 ヘクサル・アクチエンゲゼルシャフト 活性成分パッチ
US5503844A (en) * 1993-05-18 1996-04-02 Mli Acquisition Corp. Ii Foam laminate transdermal patch
CA2171435C (en) 1993-09-09 2005-04-05 Thomas Gergely Effervescent granulated material and method for its preparation
ATE162110T1 (de) 1993-11-12 1998-01-15 Gregely Gerhard Verfahren zum herstellen von granulat
RU2043099C1 (ru) * 1994-01-31 1995-09-10 Анатолий Евгеньевич Добротворский Фармацевтическая композиция в форме шипучих таблеток и способ ее получения
US5484608A (en) * 1994-03-28 1996-01-16 Pharmavene, Inc. Sustained-release drug delivery system
GB2290965A (en) 1994-07-11 1996-01-17 Therapicon Srl Multiple layer capsules for drugs
US5603955A (en) 1994-07-18 1997-02-18 University Of Cincinnati Enhanced loading of solutes into polymer gels
HU223475B1 (hu) 1994-10-24 2004-07-28 Chinoin Gyógyszer és Vegyészeti Termékek Gyára Rt. Selegilint tartalmazó liposzoma-készítmény és eljárás ennek előállítására
DE29500718U1 (de) * 1995-01-18 1995-04-06 Rau, Reinhard, 37242 Bad Sooden-Allendorf Element einer Zeltplane zum Aufbau von kohten- und jurtenähnlichen Zeltaufbauten
ATE219358T1 (de) 1995-11-06 2002-07-15 Somerset Pharmaceuticals Inc Sublinguale und bukkale verabreichung von selegilin

Also Published As

Publication number Publication date
JP2002509872A (ja) 2002-04-02
BR9909266A (pt) 2000-11-21
NO329143B1 (no) 2010-08-30
US6242002B1 (en) 2001-06-05
BG104841A (en) 2001-07-31
CZ300705B6 (cs) 2009-07-22
CA2326502A1 (en) 1999-10-07
BG65043B1 (bg) 2007-01-31
DE19814257A1 (de) 1999-10-07
IL138605A (en) 2005-11-20
SK284477B6 (sk) 2005-04-01
NO20004721L (no) 2000-09-21
NZ506989A (en) 2002-09-27
JP4469494B2 (ja) 2010-05-26
RU2221554C2 (ru) 2004-01-20
PT1067905E (pt) 2003-02-28
NO20004721D0 (no) 2000-09-21
CN1295463A (zh) 2001-05-16
CA2326502C (en) 2008-08-05
TR200002812T2 (tr) 2001-01-22
AU753194B2 (en) 2002-10-10
EP1067905B1 (de) 2002-09-25
CN1138529C (zh) 2004-02-18
HUP0101427A3 (en) 2001-12-28
PL343260A1 (en) 2001-07-30
HK1036010A1 (en) 2001-12-21
AU4029499A (en) 1999-10-18
IL138605A0 (en) 2001-10-31
KR100607395B1 (ko) 2006-08-02
HUP0101427A2 (hu) 2001-08-28
HU229793B1 (en) 2014-07-28
ZA200005133B (en) 2001-02-28
ES2183555T3 (es) 2003-03-16
CZ20003482A3 (en) 2001-05-16
DK1067905T3 (da) 2003-02-03
EP1067905A1 (de) 2001-01-17
SK14322000A3 (sk) 2001-07-10
UA66847C2 (uk) 2004-06-15
PL192049B1 (pl) 2006-08-31
TW580398B (en) 2004-03-21
DE59902843D1 (de) 2002-10-31
ATE224703T1 (de) 2002-10-15
WO1999049842A1 (de) 1999-10-07
KR20010042317A (ko) 2001-05-25

Similar Documents

Publication Publication Date Title
AR018829A1 (es) Formulaciones farmaceuticas solidas de rapida desintegracion, administrables via oral y procedimiento para prepararlos
ES2162517T3 (es) Composicion farmaceutica que comprende una combinacion de metformin y fibrato y su uso en la preparacion de medicamentos destinados a reducir la hiperglicemia.
CY1112510T1 (el) Φαρμακευτικο παρασκευασμα υπο τη μορφη παστας το οποιο περιεχει ενα ασταθες στα οξεα δραστικο συστατικο
DE69620606D1 (de) Feste oral anzuwendende arzeneiform
ES2168013T3 (es) Formulaciones solidas y de rapida desintegracion de cetirizina.
IL165601A0 (en) Oral pharmaceutical forms of liquid drugs having improved bioavailability
CO5190688A1 (es) Formas farmaceuticas de administracion oral al menos parcialmente retardadas cuya sustancia activa tramadol se encuentra al menos parcialmente en forma de compuesto formado in situ con una hidrosolubilidad 100 mg/ml, y procedimientos para su preparac
DK1003486T3 (da) Farmaceutisk præparat indeholdende et bruse-syre-basepar
ES2042541T3 (es) Un procedimiento de preparacion de una formulacion farmaceutica de liberacion retardada que contiene goma de xantano.
SE8902288L (sv) Farmaceutisk komposition
AR010634A1 (es) Composicion farmaceutica en forma de una solucion para la administracion de inhibidores de proteasa hiv
MY122124A (en) Solid pharmaceutical composition containing benzofurane derivatives
YU53101A (sh) Tableta sa produženim oslobađanjem gliklazida posle oralne primene
ES2149979T3 (es) Composicion estabilizada para la administracion oral de peptidos.
UA27058C2 (uk) Фармацевтичhа композиція, що призhачеhа для одержаhhя порошків або шипучих таблеток, яка містить ефективhу кількість ібупрофеhу, фармацевтичhий препарат hа її осhові та спосіб його одержаhhя
IT1270239B (it) Composizione farmaceutica solida contenente acido (s)-2-(4- isobutilfenil) propionico come principio attivo
IT1217445B (it) Composizione farmaceutiche orosolubili contenti acetilcisteina
EA199900102A1 (ru) Таблетка малеата тримебутина, покрытая оболочкой
NO950134L (no) Formuleringer for oralt administrerte farmasöytiske midler
MXPA05008403A (es) Uso de acido comestible en formas de dosis solidas farmaceuticas de rapida dispersion.
WO2003061557A3 (en) Levothyroxine pharmaceutical compositions, methods of making and methods of administration
HRP20000781B1 (hr) Šumeći pripravci
ATE291421T1 (de) Pharmazeutische, ramipril enthaltende brauseformulierung
ATE300293T1 (de) Pharmazeutische zusammensetzungen, die schwerlösliche arzneistoffe enthalten
ES8303915A1 (es) "procedimiento para la preparacion de comprimidos a base del antibiotico fosfomicina".

Legal Events

Date Code Title Description
FA Abandonment or withdrawal